From: Prognostic value of suPAR and hsCRP on acute kidney injury after cardiac surgery
Variable | Total | No AKI | AKI | p value | |||
---|---|---|---|---|---|---|---|
n = 924 | n = 597 | n = 327 | |||||
Preoperative data | |||||||
Age | 67 | (59–73) | 67 | (59–73) | 68 | (59–74) | 0.08 |
Male sex | 738 | (79.9) | 470 | (78.7) | 268 | (82.0) | 0.27 |
Body Mass Index (kg m2 − 1) | 26.8 | (24.2–29.9) | 26.9 | (24.0-29.4) | 27.5 | (24.8–31.2) | < 0.001 |
Diabetes mellitus | 0.02 | ||||||
No | 740 | (80.1) | 494 | (82.7) | 246 | (75.2) | - |
NIDDM | 131 | (14.2) | 73 | (12.2) | 58 | (17.7) | - |
IDDM | 53 | (5.7) | 30 | (5.0) | 23 | (7.0) | - |
Arterial hypertension | 588 | (63.6) | 357 | (59.8) | 231 | (70.6) | 0.001 |
EuroSCORE IIa | 1.66 | (1.01–3.05) | 1.46 | (0.92–2.54) | 2.48 | (1.36–4.38) | < 0.001 |
Smoking status | 0.45 | ||||||
Never | 272 | (29.4) | 172 | (28.8) | 100 | (30.6) | - |
Previous | 494 | (53.5) | 316 | (52.9) | 178 | (54.4) | - |
Active | 158 | (17.1) | 109 | (18.3) | 49 | (15.0) | - |
Previous PCI | 141 | (15.3) | 94 | (15.7) | 47 | (14.4) | 0.63 |
NYHA class | 0.01 | ||||||
I | 273 | (29.5) | 194 | (32.5) | 79 | (24.2) | - |
II | 382 | (41.3) | 245 | (41.0) | 137 | (41.9) | - |
III | 232 | (2.1) | 140 | (23.5) | 92 | (28.1) | - |
IV | 37 | (4.0) | 18 | (3.0) | 19 | (5.8) | - |
CCS 4b | 40 | (4.6) | 28 | (4.9) | 12 | (3.9) | 0.51 |
LVEF | 55 | (45–60) | 60 | (45–60) | 55 | (45–60) | 0.01 |
Prev. cardiac surgery | 59 | (6.4) | 25 | (4.2) | 34 | (10.4) | < 0.001 |
Chronic lung disease | 81 | (8.8) | 49 | (8.2) | 32 | (9.8) | 0.47 |
Extracardiac arteriopathy | 101 | (10.9) | 58 | (9.7) | 43 | (13.1) | 0.12 |
Pulmonary hypertension | 0.002 | ||||||
No | 805 | (87.1) | 537 | (89.9) | 268 | (82.0) | - |
Moderate (31–55 mmHg) | 105 | (11.4) | 53 | (8.9) | 52 | (15.9) | - |
Severe (> 55 mmHg) | 14 | (1.5) | 7 | (1.2) | 7 | (2.1) | - |
Urgency | 264 | (28.6) | 183 | (30.7) | 81 | (24.8) | 0.07 |
MI within 90 days | 184 | (19.9) | 113 | (18.9) | 71 | (21.7) | 0.34 |
Baseline serum creatinine (µmol l− 1) | 85 | (74–99) | 83 | (73–95) | 88 | (78–106) | < 0.001 |
Creatinine clearance | 84 | (66–106) | 86 | (68–107) | 79 | (62–104) | 0.005 |
Estimated glomerular filtration rate (ml min− 1 1.73 m2 − 1) | 78 | (65–90) | 81 | (68–91) | 73 | (59–88) | < 0.001 |
hsCRP (mg l− 1)c | 1.9 | (1.0-4.5) | 1.9 | (1.0-4.3) | 2.0 | (1.0-4.9) | 0.16 |
suPAR (ng ml− 1) | 2.6 | (2.0-3.4) | 2.4 | (1.9–3.1) | 2.9 | (2.2–4.1) | < 0.001 |
Intraoperative data | |||||||
Procedure | < 0.001 | ||||||
CABG | 458 | (49.6) | 343 | (57.5) | 115 | (35.2) | - |
AVR | 140 | (15.2) | 101 | (16.9) | 39 | (11.9) | - |
Other single procedure | 58 | (6.3) | 39 | (6.5) | 19 | (5.8) | - |
2 procedures | 195 | (21.1) | 90 | (15.1) | 105 | (32.1) | - |
≥ 3 procedures | 73 | (7.9) | 24 | (4.0) | 49 | (15.0) | - |
Surgery on thoracic aorta | 59 | (6.4) | 29 | (4.9) | 30 | (9.2) | 0.01 |
CPB durationd | 93 | (72–125) | 85 | (67–106) | 120 | (87–156) | < 0.001 |
Aorta-clamp-timee | 60 | (43–87) | 55 | (39–75) | 83 | (52–114) | < 0.001 |